Development of a Glycan Vaccine for Tuberculosis

Glycans are an important component of surface molecules in tuberculosis but their role in protective immunity is still largely unexplored. Carlos Rivera-Marrero and Richard D. Cumming of Emory University in the U.S. will develop high-throughput glycan microarrays to identify glycan antigens, determine their chemical structure, and design glycan-peptide vaccines for future testing.